The role of investigative molecular toxicology in early stage drug development

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.2, Iss.2, 2003-03, pp. : 147-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Transcellular Assay to Assess the P-gp Inhibition in Early Stage of Drug Development

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 285-291

Bentham Science Publishers

Access to resources Recommend Favorite

The role of early in vivo toxicity testing in drug discovery toxicology

By Fielden Mark R Kolaja Kyle L

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 107-110

Informa Healthcare

Access to resources Recommend Favorite

The Role of Genetic Toxicology in Drug Discovery and Optimization

Current Drug Metabolism, Vol. 9, Iss. 9, 2008-11 ,pp. : 978-985

Bentham Science Publishers

Access to resources Recommend Favorite

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development

By Talbot P.S. Laruelle M.

European Neuropsychopharmacology, Vol. 12, Iss. 6, 2002-12 ,pp. : 503-511

Elsevier

Access to resources Recommend Favorite

Incorporating Genome-Based Technologies into Toxicology and Safety Assessments for Drug Discovery and Development

By Yengi Lilian G.

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 6, 2007-01 ,pp. : 427-438

Adis International

Access to resources Recommend Favorite